These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17363959)

  • 1. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors.
    Kommareddy S; Amiji M
    Cancer Gene Ther; 2007 May; 14(5):488-98. PubMed ID: 17363959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1.
    Oba M; Vachutinsky Y; Miyata K; Kano MR; Ikeda S; Nishiyama N; Itaka K; Miyazono K; Koyama H; Kataoka K
    Mol Pharm; 2010 Apr; 7(2):501-9. PubMed ID: 20178335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
    Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
    Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice.
    Kim WJ; Yockman JW; Jeong JH; Christensen LV; Lee M; Kim YH; Kim SW
    J Control Release; 2006 Sep; 114(3):381-8. PubMed ID: 16884805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
    Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
    Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts.
    Gao ZN; Wei YQ; Yang PS; Xu X; Zhao HQ; Huan X; Kang B
    Oral Oncol; 2007 May; 43(5):477-83. PubMed ID: 16997614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles.
    Vachutinsky Y; Oba M; Miyata K; Hiki S; Kano MR; Nishiyama N; Koyama H; Miyazono K; Kataoka K
    J Control Release; 2011 Jan; 149(1):51-7. PubMed ID: 20138936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.
    Bruckheimer E; Harvie P; Orthel J; Dutzar B; Furstoss K; Mebel E; Anklesaria P; Paul R
    Cancer Gene Ther; 2004 Feb; 11(2):128-34. PubMed ID: 14671672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer using micellar nanovectors inhibits corneal neovascularization in vivo.
    Iriyama A; Usui T; Yanagi Y; Amano S; Oba M; Miyata K; Nishiyama N; Kataoka K
    Cornea; 2011 Dec; 30(12):1423-7. PubMed ID: 21975440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment.
    Wang P; Zhao XH; Wang ZY; Meng M; Li X; Ning Q
    Cancer Lett; 2010 Dec; 298(1):34-49. PubMed ID: 20594639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatin-based delivery systems for cancer gene therapy.
    Nezhadi SH; Choong PF; Lotfipour F; Dass CR
    J Drug Target; 2009 Dec; 17(10):731-8. PubMed ID: 19863194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Bendrik C; Robertson J; Gauldie J; Dabrosin C
    Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC.
    Graepler F; Verbeek B; Graeter T; Smirnow I; Kong HL; Schuppan D; Bauer M; Vonthein R; Gregor M; Lauer UM
    Hepatology; 2005 Apr; 41(4):879-86. PubMed ID: 15739185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
    Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF blockade decelerates the growth of a murine experimental osteosarcoma.
    Yin D; Jia T; Gong W; Yu H; Wooley PH; Mott MP; Yang SY
    Int J Oncol; 2008 Aug; 33(2):253-9. PubMed ID: 18636145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.